SHAREHOLDER ACTION ALERT: Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. Who Suffered $250,000 Losses to Contact the Firm

LOS ANGELES, Calif./ACCESSWIRE/October 6, 2022/ Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. (“Fulgent” or “the Company”) (NASDAQ: FLGT) for violation of Articles 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the United States Securities and Exchange Commission.

Investors who purchased the Company’s securities between March 22, 2019 and August 4, 2022 inclusive (the “Class Period”) are invited to contact the Company before November 21, 2022.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to do nothing, you can remain an absent member of the group.

According to the complaint, the company made false and misleading statements to the market. Fulgent engaged in unnecessary lab testing, anti-bribery and Stark law violations, and improper billing practices. The Company was likely to become the target of regulatory interest in these practices. The Company derived revenue from these practices that were not sustainable. Based on these facts, the Company’s public statements were false and materially misleading throughout the Class Period. When the market learned the truth about Fulgent, investors suffered damage.

Join the case to recoup your losses.

Schall Law Firm represents investors worldwide and specializes in securities class action and shareholder rights litigation.

This press release may be considered attorney advertising in certain jurisdictions under applicable law and ethical requirements.

CONTACT:
Schall law firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

THE SOURCE: Schall law firm

See the source version on accesswire.com:
https://www.accesswire.com/719406/SHAREHOLDER-ACTION-ALERT-The-Schall-Law-Firm-Encourages-Investors-in-Fulgent-Genetics-Inc-With-Losses-of-250000-to-Contact- the company